-
公开(公告)号:US08383094B2
公开(公告)日:2013-02-26
申请号:US12569466
申请日:2009-09-29
申请人: Makonen Belema , Van N. Nguyen , Michael Serrano-Wu , Denis R. St. Laurent , Yuping Qiu , Min Ding , Nicholas A. Meanwell , Lawrence B. Snyder
发明人: Makonen Belema , Van N. Nguyen , Michael Serrano-Wu , Denis R. St. Laurent , Yuping Qiu , Min Ding , Nicholas A. Meanwell , Lawrence B. Snyder
IPC分类号: A61K38/20 , A61K38/21 , A61K38/47 , C07D413/04 , C07D217/00 , C07D215/00
CPC分类号: C07D207/16 , A61K31/401 , A61K31/4015 , A61K31/47 , A61K31/5377 , A61K31/70 , A61K31/7088 , C07C233/62 , C07D401/12 , C07D401/14 , C07D403/14 , C07D405/06 , C07D405/12 , C07D409/14 , C07D487/08
摘要: The present disclosure relates to compounds, compositions and methods for the treatment of hepatitis C virus (HCV) infection. Also disclosed are pharmaceutical compositions containing such compounds and methods for using these compounds in the treatment of HCV infection.
-
公开(公告)号:US20100080772A1
公开(公告)日:2010-04-01
申请号:US12569466
申请日:2009-09-29
申请人: Makonen Belema , Van N. Nguyen , Michael Serrano-Wu , Denis R. St. Laurent , Yuping Qiu , Min Ding , Nicholas A. Meanwell , Lawrence B. Snyder
发明人: Makonen Belema , Van N. Nguyen , Michael Serrano-Wu , Denis R. St. Laurent , Yuping Qiu , Min Ding , Nicholas A. Meanwell , Lawrence B. Snyder
IPC分类号: A61K38/20 , A61K38/21 , A61K31/70 , A61K31/7088 , A61K31/5377 , A61K31/47 , C07D413/04 , C07D217/00 , C07D215/00
CPC分类号: C07D207/16 , A61K31/401 , A61K31/4015 , A61K31/47 , A61K31/5377 , A61K31/70 , A61K31/7088 , C07C233/62 , C07D401/12 , C07D401/14 , C07D403/14 , C07D405/06 , C07D405/12 , C07D409/14 , C07D487/08
摘要: The present disclosure relates to compounds, compositions and methods for the treatment of hepatitis C virus (HCV) infection. Also disclosed are pharmaceutical compositions containing such compounds and methods for using these compounds in the treatment of HCV infection.
-
公开(公告)号:US20110294819A1
公开(公告)日:2011-12-01
申请号:US12974069
申请日:2010-12-21
申请人: Omar D. Lopez , Denis R. St. Laurent , Jason Goodrich , Jeffrey Lee Romine , Michael Serrano-Wu , Fukang Yang , Ramesh Kakarla , Xuejie Yang , Yuping Qiu , Lawrence B. Snyder
发明人: Omar D. Lopez , Denis R. St. Laurent , Jason Goodrich , Jeffrey Lee Romine , Michael Serrano-Wu , Fukang Yang , Ramesh Kakarla , Xuejie Yang , Yuping Qiu , Lawrence B. Snyder
IPC分类号: A61K31/421 , C07D413/14 , C07D471/04 , C07D403/14 , C07D417/14 , C07D401/14 , C07D231/12 , C07D249/08 , C07D249/12 , C07D249/06 , C07D409/14 , C07D405/14 , A61K31/422 , A61K31/496 , A61K31/427 , A61K31/438 , A61K31/444 , A61K31/4545 , A61K31/4178 , A61K31/4725 , A61P31/14 , C07D263/32
CPC分类号: A61K31/415 , A61K31/4196 , A61K31/4245 , C07D231/12 , C07D233/58 , C07D233/64 , C07D249/06 , C07D249/08 , C07D249/12 , C07D263/32 , C07D403/14 , C07D405/14 , C07D409/14 , C07D413/14 , C07D417/14 , C07D471/04
摘要: The present disclosure is generally directed to antiviral compounds, and more specifically directed to compounds which can inhibit the function of the NS5A protein encoded by Hepatitis C virus (HCV), compositions comprising such compounds, and methods for inhibiting the function of the NS5A protein.
摘要翻译: 本公开一般涉及抗病毒化合物,更具体地涉及可以抑制由丙型肝炎病毒(HCV)编码的NS5A蛋白的功能的化合物,包含这些化合物的组合物,以及用于抑制NS5A蛋白功能的方法。
-
公开(公告)号:US08362020B2
公开(公告)日:2013-01-29
申请号:US12974069
申请日:2010-12-21
申请人: Omar D. Lopez , Denis R. St. Laurent , Jason Goodrich , Jeffrey Lee Romine , Michael Serrano-Wu , Fukang Yang , Ramesh Kakarla , Xuejie Yang , Yuping Qiu , Lawrence B. Snyder
发明人: Omar D. Lopez , Denis R. St. Laurent , Jason Goodrich , Jeffrey Lee Romine , Michael Serrano-Wu , Fukang Yang , Ramesh Kakarla , Xuejie Yang , Yuping Qiu , Lawrence B. Snyder
IPC分类号: A61K31/422 , A61K31/4025 , A61K31/496 , A61K31/427 , A61K31/438 , A61K31/444 , A61K31/4545 , C07D263/32 , C07D207/09 , C07D413/14 , C07D471/04 , C07D417/14
CPC分类号: A61K31/415 , A61K31/4196 , A61K31/4245 , C07D231/12 , C07D233/58 , C07D233/64 , C07D249/06 , C07D249/08 , C07D249/12 , C07D263/32 , C07D403/14 , C07D405/14 , C07D409/14 , C07D413/14 , C07D417/14 , C07D471/04
摘要: The present disclosure is generally directed to antiviral compounds, and more specifically directed to compounds which can inhibit the function of the NS5A protein encoded by Hepatitis C virus (HCV), compositions comprising such compounds, and methods for inhibiting the function of the NS5A protein.
摘要翻译: 本公开一般涉及抗病毒化合物,更具体地涉及可以抑制由丙型肝炎病毒(HCV)编码的NS5A蛋白的功能的化合物,包含这些化合物的组合物,以及用于抑制NS5A蛋白功能的方法。
-
公开(公告)号:US07183302B2
公开(公告)日:2007-02-27
申请号:US10637099
申请日:2003-08-08
申请人: Jeffrey Lee Romine , Scott W. Martin , Lawrence B. Snyder , Michael Serrano-Wu , Milind Deshpande , Darren Whitehouse , Julie Lemm , Donald O'Boyle , Min Gao , Richard Colonno
发明人: Jeffrey Lee Romine , Scott W. Martin , Lawrence B. Snyder , Michael Serrano-Wu , Milind Deshpande , Darren Whitehouse , Julie Lemm , Donald O'Boyle , Min Gao , Richard Colonno
IPC分类号: A61K43/78 , C07D277/18
CPC分类号: C07D417/04 , A61K31/00 , A61K31/426 , A61K38/2013 , A61K38/204 , A61K38/208 , A61K38/21 , A61K38/212 , A61K45/06 , C07D277/42 , C07D417/06 , C07D417/12 , C07D417/14 , C07D513/04 , A61K2300/00
摘要: Compounds having the structure of formula I are described wherein R, R′, R1, R2, and R3 are as defined in the specification. The compounds can inhibit hepatitis C virus (HCV) replication, and in particular the function of the HCV NS5A protein.
摘要翻译: 描述了具有式I结构的化合物,其中R 1,R 2,R 1,R 2和R 3均如 规范。 该化合物可以抑制丙型肝炎病毒(HCV)复制,特别是HCV NS5A蛋白的功能。
-
公开(公告)号:US20120283264A1
公开(公告)日:2012-11-08
申请号:US13287487
申请日:2011-11-02
申请人: Andrew P. Degnan , Hong Huang , Lawrence B. Snyder , Fukang Yang , Kevin W. Gillman , Michael F. Parker
发明人: Andrew P. Degnan , Hong Huang , Lawrence B. Snyder , Fukang Yang , Kevin W. Gillman , Michael F. Parker
IPC分类号: A61K31/421 , C07D413/04 , A61K31/4439 , C07D413/14 , A61K31/444 , C07D413/10 , A61K31/497 , A61K31/506 , A61K31/498 , A61K31/501 , A61P25/18 , A61P25/28 , A61P25/16 , A61P25/30 , A61P25/22 , A61P25/24 , A61P25/08 , A61P1/04 , A61P25/06 , A61P25/00 , C07D263/24
CPC分类号: C07D413/04 , C07D263/18 , C07D413/10 , C07D413/14
摘要: The disclosure generally relates to compounds of formula I, including their salts, as well as compositions and methods of using the compounds. The compounds are ligands, agonists and partial agonists for the mGluR5 receptor and may be useful for the treatment of various disorders of the central nervous system.
摘要翻译: 本公开内容通常涉及式I化合物,包括其盐,以及使用该化合物的组合物和方法。 这些化合物是mGluR5受体的配体,激动剂和部分激动剂,并且可用于治疗中枢神经系统的各种疾病。
-
公开(公告)号:US06420349B1
公开(公告)日:2002-07-16
申请号:US09782120
申请日:2001-02-13
申请人: Lawrence B. Snyder , Zhizhen Zheng
发明人: Lawrence B. Snyder , Zhizhen Zheng
IPC分类号: A61K31695
CPC分类号: C07D413/12 , C07D261/12 , C07D413/10
摘要: This invention describes isoxazolinone compounds which possess antibacterial activity and are useful in the treatment of bacterial diseases. More particularly, isoxazolinones are provided having the formula
摘要翻译: 本发明描述了具有抗菌活性并可用于治疗细菌性疾病的异恶唑啉酮化合物。 更具体地,提供具有下式的异恶唑啉酮
-
公开(公告)号:US08691821B2
公开(公告)日:2014-04-08
申请号:US13287487
申请日:2011-11-02
申请人: Andrew P. Degnan , Hong Huang , Lawrence B. Snyder , Fukang Yang , Kevin W. Gillman , Michael F. Parker
发明人: Andrew P. Degnan , Hong Huang , Lawrence B. Snyder , Fukang Yang , Kevin W. Gillman , Michael F. Parker
IPC分类号: A01N43/58 , A01N43/60 , A61K31/50 , A61K31/495 , A01N43/40 , A61K31/44 , A01N43/76 , A61K31/42 , C07D401/00 , C07D405/00 , C07D409/00 , C07D411/00 , C07D413/00 , C07D417/00 , C07D419/00 , C07D421/00
CPC分类号: C07D413/04 , C07D263/18 , C07D413/10 , C07D413/14
摘要: The disclosure generally relates to compounds of formula I, including their salts, as well as compositions and methods of using the compounds. The compounds are ligands, agonists and partial agonists for the mGluR5 receptor and may be useful for the treatment of various disorders of the central nervous system.
摘要翻译: 本公开内容通常涉及式I化合物,包括其盐,以及使用该化合物的组合物和方法。 这些化合物是mGluR5受体的配体,激动剂和部分激动剂,并且可用于治疗中枢神经系统的各种疾病。
-
公开(公告)号:US5597931A
公开(公告)日:1997-01-28
申请号:US436809
申请日:1995-05-05
申请人: Samuel J. Danishefsky , John Masters , Wendy Young , J. Thomas Link , Richard Isaacs , Lawrence B. Snyder
发明人: Samuel J. Danishefsky , John Masters , Wendy Young , J. Thomas Link , Richard Isaacs , Lawrence B. Snyder
IPC分类号: C07C45/29 , C07C45/59 , C07C49/613 , C07C49/687 , C07C49/713 , C07C49/723 , C07C49/737 , C07C49/747 , C07C49/753 , C07C49/757 , C07C255/31 , C07C255/46 , C07D305/14 , C07D317/72 , C07D493/08 , C07D493/18 , C07F7/18 , C07D317/70
CPC分类号: C07D493/08 , C07C255/31 , C07C255/46 , C07C45/29 , C07C45/59 , C07C49/613 , C07C49/687 , C07C49/713 , C07C49/723 , C07C49/737 , C07C49/747 , C07C49/753 , C07C49/757 , C07D305/14 , C07D317/72 , C07F7/1852 , C07F7/1856 , C07C2101/14 , C07C2101/16
摘要: The present invention provides three basic routes for the total synthesis of taxol having the structure: ##STR1## The present invention also provides the intermediates produced in the above processes, processes for synthesizing these intermediates as well as analogues of taxol and nortaxol.
摘要翻译: 本发明提供了具有以下结构的紫杉醇的总合成的三种基本途径:本发明还提供了上述方法中制备的中间体,合成这些中间体的方法以及紫杉醇和北美多酚的类似物。
-
公开(公告)号:US5525731A
公开(公告)日:1996-06-11
申请号:US328415
申请日:1994-10-25
IPC分类号: C07D491/14 , C07D491/147 , C07D491/22 , C07H17/00 , A61K31/435
CPC分类号: C07D491/14 , C07H17/00
摘要: Substituted analogues of camptothecin possessing cytotoxic activity towards cancer cells, of the general structure: ##STR1## wherein E is H, CO.sub.2 R, CONH.sub.2, CONHR, CONR.sub.2, or CN; R.sup.0 and R.sup.1 are independently the same or different and are H, or a linear or branched alkyl, linear or branched alkylaryl, hydroxyalkyl or aryl group; R.sup.2, R.sup.3 and R.sup.4 are independently the same or different and are H, or a linear or branched alkyl, linear or branched alkylaryl, hydroxyalkyl or aryl group; R.sup.5, R.sup.6, R.sup.7, R.sup.8 and R.sup.9 are independently the same or different and are H, or a linear or branched alkyl, linear or branched alkylaryl or aryl group, or an alkoxy, aryloxy, hydroxyalkyl, C-glycal, nitro, cyano or aminoalkoxy group, or CO.sub.2 R, Cl, F, Br, I, SR.sup.10, NR.sup.11 R.sup.12 or OR.sup.13 ; R is H, an alkyl, aryl, alkylaryl or hydroxyalkyl group; R.sup.10, R.sup.11 and R.sup.12 are independently the same or different and are H, an alkyl, aryl, alkylaryl or acyl group; R.sup.13 is glycosyl; and n is 0 or 1. Also provided are compositions comprising the analogues and methods of treating tumors as well as methods for preparing the analogues.
摘要翻译: 具有一般结构的具有对癌细胞的细胞毒性活性的喜树碱的取代类似物:其中E是H,CO 2 R,CONH 2,CONHR,CONR 2或CN; R 0和R 1独立地相同或不同,为H,或直链或支链烷基,直链或支链烷基芳基,羟烷基或芳基; R2,R3和R4独立地相同或不同,为H,或直链或支链烷基,直链或支链烷基芳基,羟基烷基或芳基; R 5,R 6,R 7,R 8和R 9独立地相同或不同,为H,或直链或支链烷基,直链或支链烷基芳基或芳基,或烷氧基,芳氧基,羟基烷基,C-缩醛,硝基,氰基或 氨基烷氧基或CO2R,Cl,F,Br,I,SR10,NR11R12或OR13; R是H,烷基,芳基,烷基芳基或羟烷基; R 10,R 11和R 12独立地相同或不同,为H,烷基,芳基,烷基芳基或酰基; R13是糖基; 并且n为0或1.还提供了包含治疗肿瘤的类似物和方法的组合物以及制备类似物的方法。
-
-
-
-
-
-
-
-
-